Please register and share with your country counterparts
Webinar: National Pharmaceutical Services Units (NPSUs) - A Critical Component for Medicines Availability and Use
Wednesday, February 21, 2024 8:00-9:30 am ET / 1:00-2:30 pm UTC
National pharmaceutical services units (NPSUs) are central government divisions responsible for medicines regulation, health supply chain, and pharmaceutical services. They impact the government’s ability to serve as stewards of the health system and ensure equitable and easy access to safe, effective, quality, affordable medical products and related services.
Many low- and middle-income countries (LMICs) are challenged by institutional capacity for important administrative and operational aspects such as pharmaceutical policy formulation, implementation, oversight, and promotion of quality and appropriate use of medical products. These have seemingly become fragmented or abandoned.
Strong linkages between policymaking, clinical and pharmacological expertise, and other areas of technical expertise (e.g., infection prevention and control) are essential to respond to these health crises effectively.
On February 21, 2024, at 8:00-9:30 am ET / 1:00-2:30 pm UTC, the USAID MTaPS Program will host a webinar showcasing the findings of a study conducted by the USAID MTaPS Program that offers guidance for the mandate and function of NPSUs in LMICs. This webinar will assist country leaders in pharmaceutical systems and those that support them to:
- Consider the mandate, functions, and roles of national pharmaceutical units.
- Reflect on current country level pharmaceutical governance and what steps can be taken to further strengthen those pharmaceutical systems.
Panelists
• Ndinda Kusu, MTaPS Kenya Program Director
• Herodias Ahimon, MTaPS Cote D’Ivoire Senior Technical Advisor
• [Kenya government official]
• [Cote D’Ivoire government official]
About USAID MTaPS
The six-year USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program (2018–2024) will help low- and middle-income countries strengthen their pharmaceutical systems to ensure people have sustainable access to safe, effective, quality-assured, and affordable essential medicines, and to pharmaceutical services that ensure their appropriate use. The US Agency for International Development (USAID) funds the program. Management Sciences for Health (MSH) leads the consortium of partners implementing it. Learn more